Global Drug Bioavailability Enhancement Summit 2023: Formulation and Delivery Technologies for Improving Drug Product Performance and Bioavailability (Princeton, NJ, United States - May 16-17, 2023) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "2023 Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.com's offering.
Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry's leading drug product development Summit. Attend and uncover industry's latest formulation and delivery technologies for improving drug product performance and bioavailability.
Benefit from 30+ expert sessions and panels including:
- Targeted and Modified Delivery
- Model-Guided Formulation Design
- Nucleic Acid Delivery for Enabling MRNA
- Long-Acting Injectables - Biopharmaceutics & Product Design
- Rational Design of Oral Formulation
- Spray Conjealing to Enhance Bioavailability
- Advancing IVIVC of Subcutaneous Bioavailability
- MED 3D Printing for Oral Bioavailability
- Selection of Membrane-Permeable Peptides
- and many more sessions and panels
2022's Speakers Included:
Pratik Saha, PhD
Director, Biopharmaceutics, Pharmaceutical Development
GlaxoSmithKline
Dipen Desai, PhD
Vice President, Complex Product Development
Amneal
Arijit Chakravarty, PhD
Chief Executive Officer
Fractal Therapeutics
Manuel Sanchez-Felix, PhD
Senior Fellow, Novel Delivery Technologies
Novartis Institute for Biomedical Research
Ramesh Palaparthy, PhD
Executive Director, Clinical Pharmacology
Gilead Sciences
Wenzhan Yang, PhD
Senior Scientist, Pharmaceutical Development
AstraZeneca
Arul Joseph, PhD
Senior Director, CMC Pharmaceutical Dev
Otsuka Pharmaceuticals
Gillie Roth, PhD
Scientist, Preclinical & Translational PKPD
Genentech
Mikhail Murashov, PhD
Senior Scientist, Preclinical Development
Merck & Co.
Hamsini Dhoolypala, PhD
Senior Associate Scientist, Pharmacokinetics
Amgen
Debanjan Das, PhD
Senior Associate Director & Science Fellow
Bayer
Ingrid Liu, PhD
Senior Scientist, Oral Formulation Sciences
Merck & Co.
Xiaoling Li, PhD
Co-Founder & CEO
Triasek
Iriny Ekladious, PhD
Associate Principal Scientist, Sterile and Specialty Products
Merck & Co.
Santipharp Panmai, PhD
Vice President and Head of Early-phase Formulation Development
WuXi STA
Nitin Swarnakar, PhD
North American Pharma Applications Manage
BASF
For more information about this conference visit https://www.researchandmarkets.com/r/cqg4t2
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Editor Details
-
Company:
- Businesswire
